In general, if the atoms that make up the ring contain heteroatoms, such rings become heterocycles, and organic compounds containing heterocycles are called heterocyclic compounds. An article called Design, synthesis, and biological evaluation of novel urolithins derivatives as potential phosphodiesterase II inhibitors, published in 2021-12-31, which mentions a compound: 4360-63-8, Name is 2-Bromomethyl-1,3-dioxolane, Molecular C4H7BrO2, Application of 4360-63-8.
A series of urolithins derivatives I (R = Et, Pr, (2-fluorophenyl)methyl, etc.) and II (R = Et, i-Pr, oxolan-2-ylmethyl, etc.) were designed and synthesized, and their structures have been confirmed by 1H NMR, 13C NMR, and HR-MS. The inhibitory activity of these derivatives I and II on phosphodiesterase II (PDE2) was thoroughly studied with 3-hydroxy-8-methyl-6H-benzo[C]chromen-6-one and 3-hydroxy-7,8,9,10-tetrahydro-6H-benzo[C] chromen-6-one as the lead compounds The biol. activity test showed that compound I (R = n-pentyl) had the best inhibitory activity on PDE2 with an IC50 of 33.95μM. This study provides a foundation for further structural modification and transformation of urolithins to obtain PDE2 inhibitor small mols. with better inhibitory activity.
Here is just a brief introduction to this compound(4360-63-8)Application of 4360-63-8, more information about the compound(2-Bromomethyl-1,3-dioxolane) is in the article, you can click the link below.
Reference:
1,3-Benzodioxole – Wikipedia,
Dioxole | C3H4O2 – PubChem